La ERS contraria alla cosiddetta strategia di riduzione del danno proposta dall’industria del tabacco

Leggi Differenze tra le posizioni attuali dell’ERS e quelle del 2019


Tzu-Hsuan Chen D, Grigg J, Filippidis FT, et al. European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and “harm reduction”. Eur Respir J 2024.


  1. World Health Organization. Novel and emerging nicotine and tobacco products, Health effects, research needs and provisional recommended actions for regulators, Report on a regional consultation Cairo, Egypt 3-4 July 2019. World Health Organization. Regional Office for the Eastern Mediterranean;2020.
  2. World Health Organisation. Technical workshop on Novel and Emerging Nicotine and Tobacco Products, . 2022; Accessed Oct 1, 2022.
  3. World Health Organization. Electronic nicotine and non-nicotine delivery systems: a brief. World Health Organization. Regional Office for Europe;2020.
  4. Wang TW, Gentzke AS, Neff LJ, et al. Disposable E-Cigarette Use among U.S. Youth — An Emerging Public Health Challenge. N Engl J Med. 2021;384(16):1573-1576.
  5. Willett JG, Bennett M, Hair EC, et al. Recognition, use and perceptions of JUUL among youth and young adults. Tobacco Control. 2019;28(1):115.
  6. World Health Organization. Heated tobacco products: a brief. World Health Organization. Regional Office for Europe;2020.
  7. Tobacco Tactics. Newer Nicotine and Tobacco Products. 2022; Accessed Oct 10, 2022.
  8. Valen H, Becher R, Vist GE, et al. A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco. Int J Cancer. 2023;153(12):1942-1953.
  9. Brose LS, McDermott MS, McNeill A. Heated Tobacco Products and Nicotine Pouches: A Survey of People with Experience of Smoking and/or Vaping in the UK. Int J Environ Res Public Health. 2021;18(16).
  10. Salokannel M, Ollila E. Snus and snus-like nicotine products moving across Nordic borders: Can laws protect young people? Nordic Studies on Alcohol and Drugs. 2021;38(6):540-554.
  11. Robichaud MO, Seidenberg AB, Byron MJ. Tobacco companies introduce ‘tobaccofree’nicotine pouches. Tobacco Control. 2020;29(e1):e145-e146.
  12. Lenton S, Single E. The definition of harm reduction. Drug Alcohol Rev. 1998;17(2):213-219.
  13. Harm Reduction International. What is Harm Reduction? A position statement. 2022; Accessed Nov 1, 2022.
  14. STOP. Addiction At Any Cost: The Truth About Philip Morris International. 2020; Accessed Oct 10, 2022.
  15. Truth Initiative. Flavoured tobacco use among youth and young adults. 2021; Accessed Oct 1, 2022.
  16. US Department of Health and Human Services. e-Cigarette use among youth and young adults: a report of the Surgeon General. 2016.
  17. Banks E, Yazidjoglou A, Joshy G. Electronic cigarettes and health outcomes: epidemiological and public health challenges. Int J Epidemiol. 2023;52(4):984-992.
  18. World Health Organisation. WHO report on the global tobacco epidemic, 2021: Addressing new and emerging products. Geneva: World Health Organization; 2021.
  19. Australian Government Department of Health. Non-nicotine liquids for e-cigarette devices in Australia: chemistry and health concerns. National Industrial Chemicals Notification and Assessment Scheme, ; 2 October 2019 2019.
  20. Wills TA, Soneji SS, Choi K, Jaspers I, Tam EK. E-cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies. Eur Respir J. 2021;57(1).
  21. Lu F, Yu M, Chen C, et al. The Emission of VOCs and CO from Heated Tobacco Products, Electronic Cigarettes, and Conventional Cigarettes, and Their Health Risk. Toxics. 2022;10(1):8.
  22. Alayna PT, Robert U, Jessica B-T, et al. Prospective study of e-cigarette use and respiratory symptoms in adolescents and young adults. Thorax. 2023:thoraxjnl-2022-218670.
  23. King BA, Jones CM, Baldwin GT, Briss PA. The EVALI and Youth Vaping Epidemics — Implications for Public Health. N Engl J Med. 2020;382(8):689-691.
  24. Philip Morris International. Heat-not-burn products. Accessed Oct 11, 2022.
  25. Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A. Heat-not-burn tobacco cigarettes: smoke by any other name. JAMA internal medicine. 2017;177(7):1050-1052.
  26. Cho H-J. Comparison of the risks of combustible cigarettes, e-cigarettes, and heated tobacco products. jkma. 2020;63(2):96-104.
  27. Flanders WD, Lally CA, Zhu BP, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res. 2003;63(19):6556-6562.
  28. Paulina M, Mateusz J, Grzegorz Marek B. Acute health effects of Heated Tobacco Products – comparative analysis with traditional cigarettes and electronic cigarettes in young adults. ERJ Open Research. 2023:00595-02022.
  29. Sukhwinder Singh S, Mathew Suji E, Vegi GMN, Pawan S. IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Research. 2019;5(1):00159-02018.
  30. Fried ND, Gardner JD. Heat-not-burn tobacco products: an emerging threat to cardiovascular health. American Journal of Physiology-Heart and Circulatory Physiology. 2020;319(6):H1234- H1239.
  31. Simonavicius E, McNeill A, Shahab L, Brose LS. Heat-not-burn tobacco products: a systematic literature review. Tobacco Control. 2019;28(5):582.
  32. Gholap VV, Kosmider L, Golshahi L, Halquist MS. Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes? Expert Opinion on Drug Delivery. 2020;17(12):1727-1736.
  33.  Mallock N, Schulz T, Malke S, Dreiack N, Laux P, Luch A. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches. Tobacco Control. 2022:tobaccocontrol-2022-057280.
  34. Alizadehgharib S, Lehrkinder A, Alshabeeb A, Östberg AK, Lingström P. The effect of a nontobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus). Eur J Oral Sci. 2022;130(4):e12885.
  35. Pisinger C, Dagli E, Filippidis FT, et al. ERS and tobacco harm reduction. Vol 54: Eur Respiratory Soc; 2019.
  36. Tattan-Birch H, Hartmann-Boyce J, Kock L, et al. Heated tobacco products for smoking cessation and reducing smoking prevalence. Cochrane Database of Systematic Reviews. 2022(1).
  37. Vainio H, Sasco AJ. A smoke screen to keep the controversy alive. Scand J Work Environ Health. 1997;23(6):401-402.
  38. Karen E-R, Kathrin L, Rosemary H. The ‘filter fraud’ persists: the tobacco industry is still using filters to suggest lower health risks while destroying the environment. Tobacco Control. 2022;31(e1):e80.
  39. White C. Tobacco industry knowingly duped public with “low tar” brands. BMJ. 2002 Mar 16;324(7338):633.
  40. Pisinger C, Godtfredsen N, Bender AM. A conflict of interest is strongly associated with tobacco industry–favourable results, indicating no harm of e-cigarettes. Prev Med. 2019;119:124-131.
  41. Hartmann-Boyce J, McRobbie H, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane database of systematic reviews. 2021(9).
  42. Hartmann-Boyce J, Lindson N, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews. 20220(11).
  43. Pisinger C. Why public health people are more worried than excited over e-cigarettes. BMC Med. 2014;12(1):226.
  44. Chen DT-H. Dual and poly-use of novel and conventional nicotine and tobacco product use in Europe: Challenges for population health, regulatory policies, and the ways ahead. Frontiers in Public Health. 2023;11.
  45. World Health Organisation. Tobacco: E-cigarettes. 2022; Accessed Oct 10, 2022.
  46. Baenziger ON, Ford L, Yazidjoglou A, Joshy G, Banks E. E-cigarette use and combustible tobacco cigarette smoking uptake among non-smokers, including relapse in former smokers: umbrella review, systematic review and meta-analysis. BMJ Open. 2021;11(3):e045603.
  47. Ayo-Yusuf OA, Burns DM. The complexity of ‘harm reduction’ with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries. Tobacco Control. 2012;21(2):245.
  48. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by public health England. London: Public Health England. 2018;6.
  49. Raffensperger C, Tickner JA. Protecting public health and the environment: implementing the precautionary principle. Island Press; 1999.
  50. World Health Organisation. Two new tobacco cessation medicines added to the WHO essential medicines list. 2023; Accessed Dec 19, 2023.
  51. European Commission. Special Eurobarometer 506—Attitudes of Europeans towards Tobacco and Electronic Cigarettes. . 2020; Accessed August 2022, 2022.
  52. Sung HY, Wang Y, Yao T, Lightwood J, Max W. Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012-2014. Nicotine Tob Res. 2018;20(suppl_1):S88-s98.
  53. Buss V, Kock L, West R, Beard E, Kale D, Brown J. Discover Major Findings Relating to Smoking in England. 2023; Accessed August 21, 2023.
  54. Laverty AA, Vardavas CI, Filippidis FT. Prevalence and reasons for use of Heated Tobacco Products (HTP) in Europe: an analysis of Eurobarometer data in 28 countries. Lancet Reg Health Eur. 2021;8:100159.
  55. Feliu A, Fernandez E, Martinez C, Filippidis FT. Are smokers “hardening” or rather “softening”? An ecological and multilevel analysis across 28 European Union countries. Eur Respir J. 2019;54(3).
  56. Jung B, Lee JA, Kim Y-J, Cho H-J. The smoking population is not hardening in South Korea: a study using the Korea Community Health Survey from 2010 to 2018. Tobacco Control. 2022:tobaccocontrol-2022-057332.
  57. Veena KP, Mathews E, Kodali PB, Thankappan KR. Trends and correlates of hardcore smoking in India: findings from the Global Adult Tobacco Surveys 1 & 2. Wellcome Open Res. 2021;6:353. 58. Organization WH. European tobacco use: Trends report 2019. World Health Organization. Regional Office for Europe;2019